Could immune drugs stop repeat miscarriages after IVF? new trial tests combo therapy
NCT ID NCT04701034
First seen Nov 24, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This study tested whether a combination of intravenous immunoglobulin (IVIg) and prednisolone can help women with unexplained recurrent pregnancy loss after assisted reproductive technology (like IVF) have a successful pregnancy. Eighty women received either the active drugs or a placebo during early pregnancy. The goal was to see if the treatment increased the chance of a live birth by calming the immune system, which may play a role in miscarriage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT PREGNANCY LOSS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
• The Centre for Recurrent Pregnancy Loss of Western Denmark, Department of Obstetrics and Gynaecology, Aalborg University Hospital
Aalborg, 9000, Denmark
Conditions
Explore the condition pages connected to this study.